Haemonetics Corporation (FRA:HAZ)
69.00
-0.50 (-0.72%)
At close: Dec 4, 2025
Haemonetics Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | 2020 - 2016 |
| Market Capitalization | 3,378 | 2,931 | 4,018 | 3,842 | 2,957 | 4,843 | Upgrade
|
| Market Cap Growth | -16.06% | -27.06% | 4.57% | 29.95% | -38.95% | 5.76% | Upgrade
|
| Enterprise Value | 4,175 | 3,827 | 4,644 | 4,341 | 3,451 | 4,956 | Upgrade
|
| Last Close Price | 71.50 | 57.50 | 78.50 | 75.50 | 56.50 | 93.00 | Upgrade
|
| PE Ratio | 23.48 | 18.93 | 36.87 | 36.17 | 75.24 | 71.65 | Upgrade
|
| PS Ratio | 2.97 | 2.33 | 3.31 | 3.57 | 3.29 | 6.54 | Upgrade
|
| PB Ratio | 4.65 | 3.87 | 4.51 | 5.10 | 4.36 | 7.78 | Upgrade
|
| P/TBV Ratio | - | - | - | 54.93 | - | - | Upgrade
|
| P/FCF Ratio | 15.42 | 22.29 | 30.18 | 51.08 | 43.08 | 79.34 | Upgrade
|
| P/OCF Ratio | 13.66 | 17.47 | 23.85 | 15.29 | 18.95 | 52.33 | Upgrade
|
| EV/Sales Ratio | 3.66 | 3.05 | 3.83 | 4.04 | 3.84 | 6.69 | Upgrade
|
| EV/EBITDA Ratio | 13.48 | 11.65 | 16.96 | 18.72 | 19.87 | 31.60 | Upgrade
|
| EV/EBIT Ratio | 19.22 | 16.78 | 24.23 | 28.21 | 36.22 | 58.21 | Upgrade
|
| EV/FCF Ratio | 19.07 | 29.10 | 34.89 | 57.71 | 50.28 | 81.19 | Upgrade
|
| Debt / Equity Ratio | 1.44 | 1.56 | 0.91 | 1.02 | 1.12 | 1.08 | Upgrade
|
| Debt / EBITDA Ratio | 3.40 | 3.49 | 2.86 | 3.28 | 4.14 | 4.02 | Upgrade
|
| Debt / FCF Ratio | 4.78 | 9.01 | 6.08 | 10.16 | 11.07 | 10.98 | Upgrade
|
| Asset Turnover | 0.54 | 0.59 | 0.63 | 0.62 | 0.54 | 0.56 | Upgrade
|
| Inventory Turnover | 1.50 | 1.71 | 2.07 | 1.98 | 1.50 | 1.49 | Upgrade
|
| Quick Ratio | 0.92 | 0.88 | 1.29 | 1.85 | 0.95 | 1.26 | Upgrade
|
| Current Ratio | 1.64 | 1.62 | 2.56 | 3.06 | 1.71 | 2.74 | Upgrade
|
| Return on Equity (ROE) | 19.47% | 18.83% | 13.22% | 14.72% | 5.86% | 12.05% | Upgrade
|
| Return on Assets (ROA) | 6.36% | 6.65% | 6.26% | 5.51% | 3.57% | 4.05% | Upgrade
|
| Return on Capital (ROIC) | 7.40% | 7.84% | 7.42% | 6.46% | 4.23% | 4.88% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.30% | 13.20% | 10.90% | 9.90% | 7.40% | 6.40% | Upgrade
|
| Earnings Yield | 4.26% | 5.28% | 2.71% | 2.76% | 1.33% | 1.40% | Upgrade
|
| FCF Yield | 6.48% | 4.49% | 3.31% | 1.96% | 2.32% | 1.26% | Upgrade
|
| Buyback Yield / Dilution | 4.63% | 1.30% | 0.04% | -0.13% | -0.12% | 1.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.